Abstract
ObjectiveMonitoring B-type natriuretic peptide (BNP) to guide pharmacotherapy might improve survival in patients with heart failure with reduced ejection fraction (HFrEF) or preserved ejection fraction (HFpEF). However, the cost-effectiveness of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have